Catalyst Wire Dossier Catalyst Wire Dossier

DTPa-HBV-IPV/Hib vaccine (new formulation)

DTPa-HBV-IPV/Hib · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTPa-HBV-IPV/Hib vaccine (new formulation), covering 2009-08-10 to 2009-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children [Phase 4]

See pricing